In the present study, we observed the synergistic anti-leukemia effect of CHI combined with CLA by inducing cell growth arrest, cell cycle arrest, and apoptosis in AML cells and identified the underlying mechanisms of the synergy through targeting HDAC2/c-Myc/RCC1 signaling in AML. Here, RCC1 is linked to leukemia.